67 related articles for article (PubMed ID: 25325557)
1. Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models.
Rodríguez-Rodríguez C; Telpoukhovskaia MA; Alí-Torres J; Rodríguez-Santiago L; Manso Y; Bailey GA; Hidalgo J; Sodupe M; Orvig C
Metallomics; 2015 Jan; 7(1):83-92. PubMed ID: 25325557
[TBL] [Abstract][Full Text] [Related]
2. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
3. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
4. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.
LeVine H
Arch Biochem Biophys; 1997 Jun; 342(2):306-16. PubMed ID: 9186492
[TBL] [Abstract][Full Text] [Related]
5. 11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
Serdons K; Verduyckt T; Vanderghinste D; Borghgraef P; Cleynhens J; Van Leuven F; Kung H; Bormans G; Verbruggen A
Eur J Med Chem; 2009 Apr; 44(4):1415-26. PubMed ID: 18992967
[TBL] [Abstract][Full Text] [Related]
6. Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease.
Telpoukhovskaia MA; Patrick BO; Rodríguez-Rodríguez C; Orvig C
Mol Biosyst; 2013 Apr; 9(4):792-805. PubMed ID: 23435553
[TBL] [Abstract][Full Text] [Related]
7. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
8. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
9. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
10. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
[TBL] [Abstract][Full Text] [Related]
11. Benzothiazole-Based Neutral Ratiometric Fluorescence Sensor for Amyloid Fibrils.
Mora AK; Murudkar S; Alamelu A; Singh PK; Chattopadhyay S; Nath S
Chemistry; 2016 Nov; 22(46):16505-16512. PubMed ID: 27727505
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits.
Cui M; Ono M; Watanabe H; Kimura H; Liu B; Saji H
J Am Chem Soc; 2014 Mar; 136(9):3388-94. PubMed ID: 24555862
[TBL] [Abstract][Full Text] [Related]
14. Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
Ono M; Haratake M; Mori H; Nakayama M
Bioorg Med Chem; 2007 Nov; 15(21):6802-9. PubMed ID: 17826102
[TBL] [Abstract][Full Text] [Related]
15. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
16. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.
Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ
Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481
[TBL] [Abstract][Full Text] [Related]
17. Electrochemical oxidation of benzothiazole dyes for monitoring amyloid formation related to the Alzheimer's disease.
Veloso AJ; Hung VW; Sindhu G; Constantinof A; Kerman K
Anal Chem; 2009 Nov; 81(22):9410-5. PubMed ID: 19831357
[TBL] [Abstract][Full Text] [Related]
18. Metal-associated amyloid-β species in Alzheimer's disease.
Pithadia AS; Lim MH
Curr Opin Chem Biol; 2012 Apr; 16(1-2):67-73. PubMed ID: 22366383
[TBL] [Abstract][Full Text] [Related]
19. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
[TBL] [Abstract][Full Text] [Related]
20. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
